New Mexico (NM) Commercial Medical Research Companies

Featured companies
Exagen Diagnostics Inc
800 Bradbury Drive Se # 108
Albuquerque NM 87106
(505) 272-7966
Ime Plus
7400 Hancock Court Ne
Albuquerque NM 87109
(505) 821-9100
Inlight Solutions Inc
800 Bradbury Drive Se # 217
Albuquerque NM 87106
(505) 272-7468
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Lovelace Scientific Resources, Inc.
2441 Ridgecrest Drive SE
Albuquerque NM 87108
(505) 348-9500

Lovelace Scientific Resources, Inc
Science Medicus Inc
539 Oliver Ross Drive Nw
Albuquerque NM 87121
(505) 944-0201
SKINfrared LLC
801 University Boulevard SE # 100
Albuquerque NM 871064345
(505) 504-6846
Katherine O'brien Md
Us Highway 491 North
Shiprock NM 87420
(505) 368-4030
PNI Institute
1335 Paseo del Pueblo Sur, Ste 159
Taos NM 87571
(575) 751-4070

Translational Reseach/Medicine with focus in Pain Management Advanced Pain Management Research and related Medical Device/Methodology R&D
Clinical Testing Laboratories Inc
3655 Research Drive
Las Cruces NM 88003
(575) 646-7850
Girx LLC
98 Herrada Road
Santa Fe NM 87508
(505) 204-7925
Whereorg has 10 results under Commercial Medical Research Companies in New Mexico.

Select a location for category Commercial Medical Research


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020